Aprix (Acetaminophen,Codeine)

Quick links to important sections

Aprix (Acetaminophen,Codeine)

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aprix (Acetaminophen,Codeine)

Property Description
Active ingredient Acetaminophen and Codeine
Form Tablet, Capsule, Oral Solution
Pharmacological class Combination Analgesic (Opioid and Non-opioid)
Common use Management of moderate to severe pain
Origin Synthetic / Semisynthetic

What Type of Medicine is Aprix (Acetaminophen, Codeine)?

Aprix (Acetaminophen, Codeine) is fundamentally defined as a fixed-dose combination product and is clinically recognized as a combination analgesic, a category of medication used specifically for pain management. This dual-component approach incorporates the non-opioid ingredient, Acetaminophen, and the opioid ingredient, Codeine, into a single medicinal entity. Combination products of this nature are typically classified as controlled substances due to the presence of the Codeine component. This classification reflects the drug's potent nature and strict requirement for a prescription status.

Active Ingredients: Acetaminophen and Codeine

The essential active components are the non-opioid Acetaminophen (Paracetamol) and the opioid Codeine (typically Codeine phosphate). Both substances are primarily of synthetic or semisynthetic origin and are formulated for oral administration, commonly supplied as a tablet or capsule. This formulation, often marketed globally under names like Co-codamol, is clinically recognized for providing enhanced pain relief compared to its individual constituents. The presence of Codeine specifically targets patients requiring relief beyond what non-opioid options can provide.

General Purpose and Synergistic Action

The general purpose of Aprix is to provide effective pain management for situations involving moderate to severe discomfort, such as acute post-surgical pain or injury-related pain, when treatment with a non-opioid analgesic alone is insufficient. This efficacy is rooted in a synergistic effect, where the combination’s therapeutic power exceeds the simple sum of its two parts. This mechanism involves the Acetaminophen addressing pain signals peripherally, while the Codeine centrally modulates pain perception, ensuring a comprehensive action against discomfort.

Regulatory References

  1. Acetaminophen and Codeine Label (DailyMed)

What side effects are possible with Aprix (Acetaminophen,Codeine)?

Possible Side Effects and Safety Information

The safety profile of Aprix (Acetaminophen, Codeine) is formally defined by the risks associated with its two components. This medicine is subject to a Boxed Warning highlighting the risks of addiction, abuse, and misuse, which can lead to overdose and death.

Serious Adverse Reactions

Due to the codeine component, serious and potentially fatal respiratory depression is a critical risk, especially at the start of therapy or following a dosage increase. The acetaminophen component poses a risk of acute liver failure, which can require liver transplant or result in death, particularly when the maximum daily dose is exceeded. Other serious documented reactions include adrenal insufficiency, severe cutaneous adverse reactions (SCARs), and serotonin syndrome when used concurrently with certain other medications.

Commonly Reported Adverse Reactions

The most commonly reported side effects include dizziness, somnolence (drowsiness), nausea, and vomiting. Other documented reactions include constipation and pruritus (itching).

Safety Restrictions and Contraindications

Specific restrictions prohibit or advise strongly against use in vulnerable populations. The medicine is contraindicated for pain in children under 12 years of age and in adolescents aged 12 to 18 years following tonsillectomy and/or adenoidectomy. It is also contraindicated in breastfeeding mothers due to the risk of serious adverse reactions, including death, in the nursing infant. Furthermore, use is restricted in individuals who are CYP2D6 ultra-rapid metabolizers due to the increased risk of dangerously high morphine levels.

Overdose and Emergency Response

The official documentation defines the overdose profile of Aprix (Acetaminophen, Codeine) by combining the severe risks of its two active components. Emergency medical care is required immediately for any suspected overdose, even if no severe symptoms are initially apparent. Individuals must contact emergency services and proceed to a hospital emergency room for evaluation.

Overdose manifestations are categorized by component. Acetaminophen toxicity initially presents with gastrointestinal signs such as nausea, vomiting, and excessive diaphoresis. Severe Acetaminophen exposure can rapidly lead to potentially fatal outcomes, including hepatic failure, metabolic acidosis, and coagulopathy. Codeine toxicity is characterized by central nervous system depression, marked by somnolence, pinpoint pupils (miosis), and shallow, reduced breathing (respiratory depression), which can progress to respiratory arrest and circulatory collapse.

Management protocols require prompt symptomatic and supportive treatment. Regulatory labels specifically note the availability of distinct antidotes for each component: N-acetylcysteine for Acetaminophen toxicity and Naloxone for Codeine toxicity. Hospital monitoring is required, including the serial assessment of liver function tests and serum concentrations. Population-specific overdose considerations note increased toxicity risks for patients with hepatic impairment and for pediatric ultra-rapid metabolizers of Codeine.

Therapeutic Uses of Aprix (Acetaminophen,Codeine)

What Aprix (Acetaminophen, Codeine) Treats: Main Uses and Benefits

This combination analgesic is commonly used to relieve symptoms related to physical discomfort in situations where the pain is significant, such as following surgical procedures or severe post-traumatic injuries. Aprix is applied when symptoms that interfere with daily functioning become intense. It provides supportive relief when non-prescription options are found to be insufficient to manage the intensity of the discomfort.

The medication is relevant in clinical settings where symptoms of systemic imbalance, specifically fever, occur alongside pain. The dual capability supports pain control and a relevant fever-reducing benefit, contributing to easing the overall symptom burden. It is generally used to address symptom clusters that may become intense or disruptive, including moderate to severe acute pain, pain refractory to standard non-opioid medications, and pain co-occurring with fever.

This therapeutic approach is often utilized during phases when symptoms become more noticeable, particularly for managing pain in contexts like certain presentations of cancer pain or episodes following invasive procedures.


“This medication is considered relevant when supportive symptom management is appropriate, especially when discomfort is temporarily overwhelming.”

Quick Fact: Relief for Moderate to Severe Acute Pain

Regulatory References

  1. MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Aprix (Acetaminophen, Codeine)?

The eligibility for Aprix is strictly defined by regulatory guidance, establishing specific populations for whom use is contraindicated or conditional.

Absolute Non-Eligibility (Contraindications)

Aprix must not be used in the following populations:

  • Children Younger Than 12 Years of Age: Contraindicated for all uses.
  • Pediatric Patients Younger Than 18 Years: Specifically contraindicated following tonsillectomy and/or adenoidectomy.
  • Breastfeeding Mothers (Lactation): Contraindicated due to the risk of serious adverse effects in the nursing infant.
  • Ultra-Rapid Metabolizers of Codeine (CYP2D6): Prohibited regardless of age due to the risk of life-threatening respiratory depression.
  • Patients with significant respiratory depression, acute bronchial asthma, or known hypersensitivity to either active ingredient.

Conditional or Restricted Use

Use requires caution or restriction in the following patient groups:

  • Adolescents (12–18 Years): Use is generally restricted to acute pain refractory to non-opioids.
  • Geriatric or Debilitated Patients: Cautious dose selection and close monitoring are mandatory.
  • Patients with severe renal or hepatic impairment: Use is conditional and requires careful assessment due to altered drug elimination.
  • Patients with a history of substance abuse or conditions that increase intracranial pressure.

What should I know about interactions with other medicines?

Aprix (Acetaminophen, Codeine) has documented interaction patterns that span absolute prohibitions, pharmacokinetic changes, and additive pharmacodynamic risks, as defined in government labeling. A major restriction is the absolute prohibition with Monoamine Oxidase Inhibitors (MAOIs), including certain specific antidepressants and agents like Linezolid, requiring a 14-day timing separation interval before or after use.

A critical risk falls under pharmacodynamic interactions, where co-administration with Central Nervous System (CNS) depressants, such as sedatives, muscle relaxants, or Alcohol (Ethanol), is officially noted to cause profound sedation and potentially fatal respiratory depression. Furthermore, concomitant use with serotonergic drugs, including Triptans and SSRIs, is documented to increase the risk of Serotonin Syndrome.

Pharmacokinetic interactions are centered on the codeine component's hepatic metabolism. Inhibitors of the CYP2D6 enzyme can decrease the conversion to the active metabolite, Morphine, which carries a risk of reduced efficacy. Conversely, CYP3A4 inhibitors and inducers officially alter Codeine plasma concentrations. The acetaminophen component is also documented to increase the anticoagulant effect of Warfarin. For special populations, individuals classified as CYP2D6 Ultra-Rapid Metabolizers carry an officially recognized risk of severe opioid toxicity.

Mechanism of Action

Dual Mechanism of Central Action

Aprix modulates central signaling pathways through its two components. Codeine functions as a prodrug, being converted to Morphine in the liver. Morphine acts as an agonist at mu-opioid receptors ( MOR) located presynaptically and postsynaptically throughout the central nervous system ( CNS). This agonism activates inhibitory G-proteins, leading to decreased influx of Ca^2+ and increased K^+ conductance, which collectively dampens ascending nociceptive signal transmission from the spinal cord to the brain.

Acetaminophen is primarily a central inhibitor of COX enzymes, resulting in reduced synthesis of PGE2 in the hypothalamus. This molecular action directly resets the hypothalamic thermoregulatory set-point, leading to set-point lowering. Furthermore, MOR activation modulates autonomic centers in the brainstem, causing a reduction in the sensitivity of the respiratory center to CO2 and decreased propulsive movements of the enteric nervous system.

Dosage and Administration Information

The administration of Aprix (Acetaminophen, Codeine) is governed by official use principles focused on oral intake, specific dosing intervals, and strict cumulative limits for the combination's two active components. The medication is officially formulated as an oral solution and various oral tablets or capsules, which is the only approved route of administration.

The standard adult dosing regimen is typically taken as needed for pain, often involving one or two unit doses repeated at a frequency of every four to six hours. A critical instruction is the cumulative limit on the non-opioid component: the total intake of Acetaminophen from all sources, including this product, must not exceed 4,000 mg (4 grams) in any 24-hour period. Compliance with this ceiling requires tracking the content of other prescription and over-the-counter medicines.

For the oral solution form, proper administration requires using a calibrated measuring device to ensure accurate volume delivery, as household spoons are not standardized. Furthermore, official labeling places explicit limitations on use in pediatric populations: the product is contraindicated in children younger than 12 years of age. Dose adjustments are also required for individuals with hepatic (liver) or renal (kidney) impairment, often necessitating a lower total daily dose or an extended time interval between administrations. If the medicine is discontinued after regular use, standard guidance requires a gradual dose taper to manage physical dependence.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Aprix (Acetaminophen, Codeine)


Evidence for Use in Moderate to Severe Acute Pain

The most comprehensive research base for Aprix was studied for its application for outcomes related to physical discomfort during episodes of moderate to severe acute pain. The evidence is mainly derived from numerous short-term, placebo-controlled Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time immediately after a single dose. Researchers primarily examined adults who were experiencing pain following surgical procedures.

In these studies, researchers monitored patient-reported outcomes describing perceived discomfort. Findings describe patterns observed in the studies where groups receiving the combination generally showed measurements related to physical discomfort that differed from those observed in the groups receiving a neutral placebo within the initial hours of dosing. Studies also monitored the need for additional pain relief medication; research highlights changes measured during the study period; findings describe patterns where patients receiving the combination were observed to have a longer time before requiring supplemental medication. These findings contribute to the broader evidence landscape regarding how patients reported their experience during the short observation period.


Long-Term Studies and Follow-Up Observations

The majority of pivotal efficacy research focused on short-term symptom patterns, with follow-up durations being limited, often lasting only for the initial hours after a dose. This focus means that there is limited information for long-term outcomes that would describe patterns of symptom changes over months or years.

The evidence derived from settings with varying symptom burdens provides context but not individual predictions about long-term stability or durability of response. While some observational data describe the usage patterns of the combination in chronic conditions, these designs do not provide the same level of information as controlled trials. Therefore, research is ongoing, and data for long-term outcomes are still insufficient.


What Research Gaps and Uncertainties Exist

The scientific literature highlights several key areas where research is still needed. A primary limitation is that results apply mainly to the populations studied in single-dose, acute pain models; these findings may not apply to every situation.

Specifically, there is a scarcity of long-term RCTs dedicated to evaluating how the combination functions over extended periods in chronic pain management. Research provides context but does not characterize the long-term outcomes of repeated, daily administration. Furthermore, the inherent variability in individual metabolic processing of the codeine component remains an area of uncertainty, meaning the reported outcomes reflect group patterns and not personal outcomes.

Frequently Asked Questions (FAQ)

Common questions about Aprix (Acetaminophen,Codeine) (FAQ)


Q: How quickly does Aprix usually start working?

A: Official regulatory information on pharmacokinetics provides the time it takes for the drug components to reach peak plasma concentrations (T max). This value is used to estimate the time required for maximum absorption. However, official documentation focuses on the time the drug reaches maximum concentration in the body, which may differ from a person's perceived onset of relief.


Q: How long do the pain-relieving effects of Aprix last?

A: Official administration instructions often recommend that the medication is taken as needed, with doses repeated every four to six hours. This frequency provides an indication of the typical duration of effect cited in the labeling. The precise frequency should be determined based on the instructions provided by a healthcare professional.


Q: What are the most common side effects of Aprix that people report online?

A: Regulatory documents list the most commonly reported adverse reactions identified in clinical studies. These frequently observed effects include feelings of dizziness, somnolence (drowsiness), nausea, and vomiting. These are highlighted because they occurred most often in the tested patient groups.


Q: Does Aprix interact with common allergy medicines?

A: Official drug labels caution against combining Aprix with Central Nervous System (CNS) depressants, a drug class that includes some allergy medicines (antihistamines). This combination officially carries a risk of profound sedation and severe respiratory depression. The potential for these effects is why concurrent use is a topic that must be discussed with a healthcare provider.


Q: Is it safe to drive or operate machinery after taking Aprix?

A: Due to the potential for dizziness, somnolence, and impairment of mental or physical abilities, official labeling contains a warning that advises against driving or operating dangerous machinery. This caution is in place because these effects could compromise alertness and motor skills.


Q: How common is constipation as a side effect of Aprix?

A: Official regulatory documents classify constipation as a common adverse reaction associated with the use of this medication. This means it was observed in a significant number of patients in clinical trials.


Q: Do people often report feeling dizzy after taking Aprix?

A: Yes, official labeling identifies dizziness as one of the most commonly reported adverse reactions documented during studies. This is a frequently observed effect that was reported in studies of the medication.


Q: Can Aprix interfere with blood pressure medications?

A: Regulatory documents state that opioid analgesics like codeine are known to cause orthostatic hypotension (a drop in blood pressure when changing posture). Official labeling therefore recommends caution when this drug is used together with other medications that affect blood pressure.


Q: How long after stopping Aprix will the codeine be out of your system?

A: The full regulatory information provides the half-life (T1/2) of Codeine and its active metabolite, Morphine. This is a pharmacokinetic value used to model the general rate at which the drug is cleared from the body. It represents the time required for the amount of drug in the body to be reduced by half.


Q: Is it safe to take over-the-counter sleep aids with Aprix?

A: Official warnings strongly caution against co-administration with other Central Nervous System (CNS) depressants, which includes many over-the-counter sleep aids. The combination presents a serious risk of profound sedation and respiratory depression.


Q: How effective is Aprix for dental pain?

A: The product is officially indicated for the management of moderate to severe pain that is severe enough to require an opioid. The official indication is for general acute pain management.


Q: What if Aprix doesn't seem to be working for my pain?

A: Regulatory documents note that certain drug interactions, specifically with CYP2D6 inhibitors, can interfere with the body's conversion of Codeine to its active form, Morphine. This metabolic interference may result in reduced efficacy for pain relief.


Q: Is Aprix used for chronic pain management?

A: Official labeling strongly focuses on the treatment of acute pain and includes warnings about the risks of addiction, abuse, and misuse associated with long-term use. For this reason, its use for long-term, chronic daily pain management is not typically recommended in official guidance.


Q: Is Aprix the same as Tylenol 3?

A: Yes, official product information confirms that Tylenol 3 is a commonly recognized brand name for a combination product containing acetaminophen and codeine. Aprix contains the identical combination of active ingredients.


Q: What kind of pain is Aprix best at treating?

A: Official indications state that the product is intended for the management of pain severe enough to require an opioid analgesic. This indication is generally applied to situations where pain is classified as moderate to severe.


Q: Is it normal to feel sleepy or drowsy after taking Aprix?

A: Yes, official labeling lists somnolence (drowsiness) and dizziness as very common adverse reactions. This is a frequently observed effect that was reported in studies of the medication.


Q: Are there generic versions of Aprix available?

A: Official drug databases, such as the FDA’s Orange Book, list all approved formulations of a drug. The combination product is listed in regulatory databases where authorized generic versions may be available.


Q: Is it possible to become dependent on Aprix if taken for a short time?

A: Official labeling contains a Boxed Warning regarding the risk of physical dependence and withdrawal symptoms. While the risk increases with repeated use over time, the management of dependence risk is a topic for discussion with a healthcare provider.


Q: Does Aprix show up on standard drug tests?

A: Official pharmacology information confirms that the codeine component is metabolized by the body into morphine. Both codeine and morphine are opioids that are detectable by many standard drug screening tests.


Q: Is there a maximum amount of time someone should take Aprix?

A: While regulatory guidelines do not usually specify an exact maximum number of days for therapy, official guidance emphasizes that the medication is intended for use for the shortest possible duration, based on the risks of addiction, abuse, and misuse.


Q: Do other medicines make Aprix work less effectively?

A: Official warnings specifically identify medicines that act as CYP2D6 enzyme inhibitors. These drugs can interfere with the body's ability to convert Codeine into its active form, Morphine, which can lead to reduced efficacy.


Q: Does Aprix treat inflammation or just pain?

A: Regulatory documents describe the medication as an analgesic (pain reliever) and antipyretic (fever reducer). The product is not officially categorized as an anti-inflammatory drug, meaning its primary action is to relieve pain and reduce fever.


Q: What is the difference between Aprix and just taking regular acetaminophen?

A: Aprix is a combination product that includes the opioid Codeine along with Acetaminophen. The key difference is the Codeine, which acts centrally to provide additional pain relief through an opioid mechanism that is not present when taking acetaminophen alone.


Q: What happens when Aprix wears off?

A: If the medication has been taken regularly, regulatory warnings advise that stopping the medicine may lead to withdrawal symptoms. Official guidance recommends that any reduction or discontinuation be done using a gradual dose taper to manage these potential effects.


Q: Is it true that codeine works differently in some people?

A: Yes, official warnings highlight that people classified as CYP2D6 ultra-rapid metabolizers process codeine much faster than average. This unique metabolism may lead to higher-than-expected levels of the active drug, Morphine, posing a significant risk.


Q: What information should I share with my doctor before starting Aprix?

A: Official labeling includes guidance for patients to share specific medical history points with their healthcare provider. This includes any conditions related to breathing, liver or kidney issues, and any personal or family history of substance abuse.


Q: Can Aprix cause strange dreams or nightmares?

A: Official documentation notes adverse reactions in the psychiatric or nervous system categories. Since the opioid component affects the central nervous system, this can include changes in sleep and behavioral patterns, which may manifest as strange dreams or nightmares.


Q: Are there any natural supplements that interact with Aprix?

A: Official warnings caution against interactions with substances that affect specific CYP enzymes involved in the metabolism of the drug. Since some natural supplements can affect these enzymes, this potential for interaction is an important consideration to discuss with a healthcare provider.


Q: What studies support the use of Aprix for moderate pain?

A: The official indication for moderate to severe pain is supported by clinical trials summarized in the drug label. These generally include short-term, placebo-controlled studies on adults experiencing acute pain, such as post-surgical discomfort.


Q: Can older people generally take Aprix safely?

A: Official labeling advises that dose selection for geriatric patients should be cautious. This is due to the greater frequency of decreased organ function in this population, which is why official guidance recommends cautious dose selection, often starting at the low end of the recommended dosing range.


How should Aprix (Acetaminophen,Codeine) be stored and disposed of?

Storage and Disposal Requirements for Acetaminophen and Codeine

Mandatory Storage Conditions

As a controlled substance, Acetaminophen and Codeine must be stored securely to prevent misuse and accidental ingestion, especially by children. The medication must be kept out of the sight and reach of children and in a location not accessible by others.

  • Environment: Store in a tightly closed container at room temperature, away from excess heat, moisture, and direct light. The product must be kept from freezing.

Official Disposal Instructions

Unused or expired Acetaminophen and Codeine must be disposed of promptly and safely.

  • Preferred Method: Utilize a drug take-back program or a DEA-registered collector.
  • Household Disposal: If no take-back option is available, the product must be mixed with an unpalatable substance (like dirt or used coffee grounds) and placed into a sealed bag before being thrown into the household trash. Personal information must be deleted from all packaging.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aprix (Acetaminophen,Codeine) found in:

A-Z Index: